Foot/Ankle News

OrthoXel announced it has received FDA 510(k) clearance and CE mark approval for the Apex tibial nailing system.

A single preoperative dose of IV cefazolin did not reduce the risk of surgical site infection within 30 days following removal of orthopedic implants used for treatment of fractures below the knee compared with saline, according to results published in JAMA.

The Interactive Expert Exchange session entitled “Forefoot pathologies: When to do open and when to do percutaneous?” scheduled for the upcoming congress in Barcelona will allow attendees focused on foot and ankle pathologies to develop or reject their position on minimally invasive techniques or traditional surgery for treatment of hallux valgus and/or Civinini-Morton syndrome.

EFORT Open Reviews is the new, open access journal from EFORT and Bone & Joint Publishing. All articles are free to read online with no subscription required.

The patient is a healthy 11-year-old, girl with chronic, right, posterolateral ankle pain. She has been able to “pop” the tendons on the outside of both ankles for 3 years. She describes the pain as sharp and throbbing which is intermittent in frequency and associated with tightness. She describes moderate relief with lace-up ankle braces and NSAIDs. The pain worsens with any prolonged physical activity. In the past, she had multiple mild ankle injuries as a cheerleader and softball player.

DePuy Synthes announced the availability of continuous compression implants for healing of reconstructive foot and ankle procedures to health care providers in Europe, the Middle East and Africa.

In2BonesGlobal Inc. announced its subsidiary In2Bones USA LLC received FDA clearance for its CoLink forefoot bone plating system to be used for bone stabilization during the postoperative healing process.

Despite similar improvements in comfort and function after ankle arthrodesis or total ankle replacement, results published in The Journal of Bone and Joint Surgery showed total ankle replacement performed with newer generation implants had better patient-reported outcomes.

DT MedTech LLC announced it has received FDA 510(k) clearance for the Hintermann Series H2 total ankle replacement system.

MedShape Inc. announced it has received FDA 510(k) clearance for the DynaNail XL tibiotalocalcaneal fusion system, which the company expects to launch in early 2018.